Drug Trial Radar · NCT03921541
Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency
Last checked: Nov 20, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
32
Actual
Start
May 1, 2019
Primary completion
Feb 1, 2023
Study completion Feb 1, 2023
Sponsor
- Lead sponsor
- Immedica Pharma ABIndustry
- Sponsor type
- Industry
- Collaborators
- Aeglea Biotherapeutics
- First posted
- Apr 19, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
CAEB1102-300A is a multi-center randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of pegzilarginase in patients with ARG1-D. This study will consist of a screening period; a randomized, double-blind treatment period; a long-term extension; and a follow up visit for final safety assessments.
Conditions
- Arginase I Deficiency
- Hyperargininemia
Interventions
PegzilarginaseDrug
Individualized disease management which includes severe protein restriction, essential amino acid supplementation and the ammonia scavengers when indicated
PlaceboDrug
Individualized disease management which includes severe protein restriction, essential amino acid supplementation and the ammonia scavengers when indicated
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Plasma Arginine Concentration After 24 Weeks of TreatmentTime frame: Baseline through Week 24
Locations
32 sites in 7 countries. Site status is shown where the registry gives one.
Harvey Pediatrics
Rogers, Arkansas
Children's Hospital of Orange County
Orange, California
Stanford University School of Medicine
Stanford, California
Children's National Medical Center
Washington D.C., District of Columbia
University of Florida College of Medicine
Gainesville, Florida
Emory University
Atlanta, Georgia
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
Icahn School of Medicine at Mount Sinai
New York, New York
Cohen Children's Medical Center (Northwell Health)
Queens, New York
Duke University Medical Center
Durham, North Carolina
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
Vanderbilt University Medical Center
Nashville, Tennessee
UT Southwestern Medical Center
Dallas, Texas
University of Texas Health Science Center Medical School at Houston
Houston, Texas
University of Utah Hospitals & Clinics
Salt Lake City, Utah
Seattle Children's Hospital
Seattle, Washington
LKH Bregenz
Bregenz, Austria
Medizinische Universität Innsbruck
Innsbruck, Austria
McGill University Health Center
Montreal, Quebec, Canada
Hôpital Necker - Enfants Malades
Paris, France
Hopital des Enfants
Talence, France
Universitaetsklinikum Muenster
Münster, North Rhine-Westphalia, Germany
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz
Mainz, Rhineland-Palatinate, Germany
Fondazione MBBM
Monza, Italy
Ospedale Pediatrico Bambino Gesù
Roma, Italy
Azienda Ospedaliera Città della Salute e della Scienza di Torino
Torino, Italy
Birmingham Children's Hospital
Birmingham, United Kingdom
University Hospital of Wales
Cardiff, United Kingdom
Great Ormond Street Hospital for Children
London, United Kingdom
Willink Biochemical Genetics Unit
Manchester, United Kingdom
Salford Royal
Salford, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.